天臣医疗
(688013)
| 流通市值：16.66亿 | | | 总市值：16.66亿 |
| 流通股本：8115.56万 | | | 总股本：8115.56万 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 173,011,182.73 | 113,337,168.31 | 55,677,592.99 | 326,733,883.44 |
| 营业总成本 | 166,860,167.64 | 109,762,773.92 | 52,954,345.86 | 243,879,907.75 |
| 其他经营收益 | | | | |
| 营业利润 | 18,811,287.71 | 14,833,474.59 | 9,612,138.98 | 95,612,202.6 |
| 利润总额 | 18,729,546.61 | 14,778,546.34 | 9,611,847.96 | 95,166,995.03 |
| 净利润 | 16,506,455.49 | 13,740,618.61 | 9,692,968.8 | 85,185,424.04 |
| 每股收益 | | | | |
| 其他综合收益 | 335,135.92 | 287,058.51 | 241,582.49 | -41,346.61 |
| 综合收益总额 | 16,841,591.41 | 14,027,677.12 | 9,934,551.29 | 85,144,077.43 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 363,995,318.18 | 328,568,774.64 | 367,589,071.24 | 376,920,852.71 |
| 非流动资产: | | | | |
| 非流动资产合计 | 353,717,690.92 | 335,825,614.27 | 326,795,414.35 | 296,007,540.47 |
| 资产总计 | 717,713,009.1 | 664,394,388.91 | 694,384,485.59 | 672,928,393.18 |
| 流动负债: | | | | |
| 流动负债合计 | 171,850,986.1 | 131,227,000.85 | 103,876,357.16 | 87,633,703.75 |
| 非流动负债: | | | | |
| 非流动负债合计 | 53,572,435.15 | 38,362,129.94 | 13,877,031.97 | 19,740,729.06 |
| 负债合计 | 225,423,421.25 | 169,589,130.79 | 117,753,389.13 | 107,374,432.81 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 492,289,587.85 | 494,805,258.12 | 576,631,096.46 | 565,553,960.37 |
| 股东权益合计 | 492,289,587.85 | 494,805,258.12 | 576,631,096.46 | 565,553,960.37 |
| 负债和股东权益合计 | 717,713,009.1 | 664,394,388.91 | 694,384,485.59 | 672,928,393.18 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 210,674,032.08 | 145,618,719.21 | 73,261,393.24 | 345,856,648.19 |
| 经营活动现金流出小计 | 184,956,140.03 | 138,786,117.67 | 75,176,920.83 | 273,870,434.78 |
| 经营活动产生的现金流量净额 | 25,717,892.05 | 6,832,601.54 | -1,915,527.59 | 71,986,213.41 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 407,114,031.55 | 311,863,358.67 | 237,216,694.33 | 553,499,166.8 |
| 投资活动现金流出小计 | 443,650,725.4 | 352,386,733.21 | 213,091,816.1 | 535,975,645.25 |
| 投资活动产生的现金流量净额 | -36,536,693.85 | -40,523,374.54 | 24,124,878.23 | 17,523,521.55 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 170,848,528.93 | 118,988,528.93 | 48,895,800 | 103,107,978.92 |
| 筹资活动现金流出小计 | 142,167,744.18 | 127,233,896.68 | 24,298,125.75 | 163,807,988.24 |
| 筹资活动产生的现金流量净额 | 28,680,784.75 | -8,245,367.75 | 24,597,674.25 | -60,700,009.32 |
| 汇率变动对现金及现金等价物的影响 | -1,200,834.62 | -146,939.94 | -261,864.59 | 5,844,853.06 |
| 现金及现金等价物净增加额 | 16,661,148.33 | -42,083,080.69 | 46,545,160.3 | 34,654,578.7 |
| 期末现金及现金等价物余额 | 115,441,614.61 | 56,697,385.59 | 169,386,123.76 | 98,780,466.28 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -42,083,080.69 | - | 34,654,578.7 |